BTAIVSRXST• 12 Months (Normalized)
BTAI vs RXST (BioXcel Therapeutics Inc. vs RxSight Inc.)
Showing Closing Date Range from Sep, 15, 2025 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
RXST Performance $5.71
-38.14%
RxSight Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
+38.14%
BTAI outperforming by 38.14%
BTAIRXST
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI RXST
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BTAI Price | BTAI Gain (%) | RXST Price | RXST Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $- | $5.71 | -38.14% | - | |
| Sep 14, 2026 | $0.05 | -98.58% | $6.11 | -33.86% | -64.72% |
| Sep 11, 2026 | $0.05 | -98.39% | $6.02 | -34.78% | -63.61% |
| Sep 10, 2026 | $0.05 | -98.42% | $5.96 | -35.43% | -62.99% |
| Sep 09, 2026 | $0.05 | -98.52% | $6.33 | -31.42% | -67.10% |
| Sep 08, 2026 | $0.04 | -98.64% | $6.45 | -30.12% | -68.52% |
| Sep 04, 2026 | $0.07 | -97.67% | $6.38 | -30.93% | -66.74% |
| Sep 03, 2026 | $0.12 | -96.28% | $6.54 | -29.14% | -67.14% |
| Sep 02, 2026 | $0.11 | -96.62% | $7.03 | -23.84% | -72.78% |
| Sep 01, 2026 | $0.14 | -95.68% | $6.99 | -24.27% | -71.41% |
| Aug 31, 2026 | $0.16 | -94.86% | $7.33 | -20.59% | -74.27% |
| Aug 28, 2026 | $0.18 | -94.29% | $7.05 | -23.62% | -70.67% |
| Aug 27, 2026 | $0.72 | -77.32% | $6.61 | -28.39% | -48.93% |
| Aug 26, 2026 | $0.78 | -75.39% | $6.38 | -30.88% | -44.51% |
| Aug 25, 2026 | $0.74 | -76.59% | $6.40 | -30.66% | -45.93% |
Page 1 of 17